Technical Analysis for ANRO - Alto Neuroscience, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | 0.50% | |
Pocket Pivot | Bullish Swing Setup | 0.50% | |
Inside Day | Range Contraction | 0.50% | |
50 DMA Resistance | Bearish | 4.97% | |
Fell Below 20 DMA | Bearish | 4.97% | |
MACD Bearish Signal Line Cross | Bearish | 4.97% |
Alert | Time |
---|---|
Down 3% | about 11 hours ago |
Down 2 % | about 11 hours ago |
Down 1% | about 11 hours ago |
60 Minute Opening Range Breakdown | about 12 hours ago |
20 DMA Resistance | about 12 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/21/2024
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Alto's Precision Psychiatry Platform™ measures brain biomarkers by analyzing EEG activity, neurocognitive assessments, wearable data, and other factors to better identify which patients are more likely to respond to Alto product candidates. Alto’s clinical-stage pipeline includes novel drug candidates in depression, PTSD, schizophrenia, and other mental health conditions.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Post Traumatic Stress Disorder Electroencephalography Neurocognition Ptsd
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Schizophrenia Biomarkers Depression Neurophysiology Post Traumatic Stress Disorder Electroencephalography Neurocognition Ptsd
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 24.0 |
52 Week Low | 12.7798 |
Average Volume | 165,908 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 14.60 |
20-Day Moving Average | 14.26 |
10-Day Moving Average | 14.43 |
Average True Range | 1.05 |
RSI (14) | 47.92 |
ADX | 13.94 |
+DI | 16.76 |
-DI | 15.30 |
Chandelier Exit (Long, 3 ATRs) | 13.40 |
Chandelier Exit (Short, 3 ATRs) | 15.92 |
Upper Bollinger Bands | 15.78 |
Lower Bollinger Band | 12.74 |
Percent B (%b) | 0.47 |
BandWidth | 21.31 |
MACD Line | -0.12 |
MACD Signal Line | -0.09 |
MACD Histogram | -0.031 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.50 | ||||
Resistance 3 (R3) | 15.47 | 14.99 | 15.27 | ||
Resistance 2 (R2) | 14.99 | 14.65 | 15.01 | 15.20 | |
Resistance 1 (R1) | 14.58 | 14.44 | 14.34 | 14.61 | 15.12 |
Pivot Point | 14.10 | 14.10 | 13.99 | 14.12 | 14.10 |
Support 1 (S1) | 13.69 | 13.76 | 13.45 | 13.72 | 13.20 |
Support 2 (S2) | 13.21 | 13.55 | 13.23 | 13.12 | |
Support 3 (S3) | 12.80 | 13.21 | 13.05 | ||
Support 4 (S4) | 12.83 |